Stocks TradingCharts.com

stocks prices, charts & quotes

Free Stock Prices, Charts & Stock Price Quotes

Search
Symbol Search Browse Symbols My Charts Menu
QUICK QUOTE
QUICK CHART
F.A.Questions Suggestion Box Advertising Info Commodity Charts Forex Markets

Stocks & Financial News

Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts

Bunge Reports First Quarter 2024 Results

ST. LOUIS, April 24, 2024 (BUSINESS WIRE) --
Bunge Global SA (NYSE: BG) today reported first quarter 2024 results.

Q1 GAAP diluted EPS of $1.68 vs. $4.15 in the prior year; $3.04 vs. $3.26 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences In Agribusiness higher Processing results were more than offset by lower results in Merchandising Refined and Specialty Oils down from a strong prior year Significant progress on Viterra integration planning and other growth initiatives Repurchased $400 million of shares during the quarter Maintaining adjusted full-year EPS outlook of approximately $9.00 Overview

Greg Heckman, Bunge's Chief Executive Officer, commented, "We are pleased with our first quarter results, which reflect our team's strong execution in a more balanced market environment. During the quarter we invested further in our pipeline of growth projects and made excellent progress on integration planning for our announced combination with Viterra."

"While we are off to a strong start, we continue to have limited visibility into the back half of the year. However, we are confident in our team's ability to stay agile and capture opportunities ahead of us as we remain focused on delivering on our mission of connecting farmers to consumers to deliver essential food, feed and fuel to the world."

Financial Highlights

                                                                          Three Months Ended
                                                                                                  March 31,
                                             ------------------------------------------------------------------------------------------------------------
(US$ in millions, except per share data)            2024               2023       
-------------------------------------------- -------------------- -------------- -------------------- -------------------- -------------- --------------------
Net income attributable to Bunge                                $            244                      $            632  
Net income per share-diluted (6)                                $           1.68                      $           4.15  
                                                                 
Mark-to-market timing differences (a)                           $           0.94                      $          (0.84                    )
Certain (gains) & charges (b)                                   $           0.42                      $          (0.05                    )
                                             -------------------- -------------- -------------------- -------------------- -------------- --------------------
Adjusted Net income per share-diluted (c)(6)                    $           3.04                      $           3.26  
                                                                 
Core Segment EBIT (c) (d)                                       $            537                      $            947  
                                                          182               (181                    )
   Mark-to-market timing differences (a)
                                               --                (10                    )
   Certain (gains) & charges (b)
                                             -------------------- -------------- -------------------- -------------------- -------------- --------------------
Adjusted Core Segment EBIT (c)                                  $            719                      $            756  
                                             -------------------- -------------- -------------------- -------------------- -------------- --------------------
                                                                 
Corporate and Other EBIT (c)                                    $           (128                    )                    $            (80                    )
                                                           61     --  
   Certain (gains) & charges (b)
                                             -------------------- -------------- -------------------- -------------------- -------------- --------------------
Adjusted Corporate and Other EBIT (c)                           $            (67                    )                    $            (80                    )
                                             -------------------- -------------- -------------------- -------------------- -------------- --------------------
                                                                 
Non-core Segment EBIT (c) (e)                                   $             24                      $             19  
                                               --     --  
   Certain (gains) & charges (b)
                                             -------------------- -------------- -------------------- -------------------- -------------- --------------------
Adjusted Non-core Segment EBIT (c)                              $             24                      $             19  
                                             -------------------- -------------- -------------------- -------------------- -------------- --------------------
                                                                 
Total Segment EBIT (c)                                          $            433                      $            886  
                                                          182               (181                    )
   Mark-to-market timing differences (a)
Certain (gains) & charges (b)                              61                (10                    )
                                             -------------------- -------------- -------------------- -------------------- -------------- --------------------
(a) Mark-to-market timing impact of certain commodity and freight contracts, readily marketable inventories, and related hedges associated with committed future operating capacity. See note 3 in the Additional Financial information section of this release for details.                                                                                                                                                                                                                       Mark-to-market timing impact of certain commodity and freight contracts, readily marketable inventories, and related hedges associated with committed future operating capacity. See note 3 in the Additional Financial information section of this release for details.
(b) Certain (gains) & charges included in Total Segment EBIT and Net income attributable to Bunge. See Additional Financial Information for details.                                                                                                                                                                                                                                     Certain (gains) & charges included in Total Segment EBIT and Net income attributable to Bunge. See Additional Financial Information for details.
(c) Core Segment EBIT, Adjusted Core Segment EBIT, Corporate and Other EBIT, Adjusted Corporate and Other EBIT, Non-core Segment EBIT, Adjusted Non-core Segment EBIT, Total Segment EBIT, Adjusted Total Segment EBIT, and Adjusted Net income per share-diluted are non-GAAP financial measures. Reconciliations to the most directly comparable U.S. GAAP measures are included in the tables attached to this press release and the accompanying slide presentation posted on Bunge's website. Core Segment EBIT, Adjusted Core Segment EBIT, Corporate and Other EBIT, Adjusted Corporate and Other EBIT, Non-core Segment EBIT, Adjusted Non-core Segment EBIT, Total Segment EBIT, Adjusted Total Segment EBIT, and Adjusted Net income per share-diluted are non-GAAP financial measures. Reconciliations to the most directly comparable U.S. GAAP measures are included in the tables attached to this press release and the accompanying slide presentation posted on Bunge's website.
(d) Core Segment earnings before interest and tax ("Core Segment EBIT") comprises the aggregate earnings before interest and tax ("EBIT") of Bunge's Agribusiness, Refined and Specialty Oils and Milling reportable segments, and excludes Bunge's Sugar & Bioenergy reportable segment and Corporate and Other activities.                                                                                       Core Segment earnings before interest and tax ("Core Segment EBIT") comprises the aggregate earnings before interest and tax ("EBIT") of Bunge's Agribusiness, Refined and Specialty Oils and Milling reportable segments, and excludes Bunge's Sugar & Bioenergy reportable segment and Corporate and Other activities.

First Quarter Results

Core Segments

Agribusiness

                                                                                                Three Months Ended
                                                                   ------------------------------------------------------------------------------------------------------------
(US$ in millions, except per share data)                                                 Mar 31, 2024                                             Mar 31, 2023
------------------------------------------------------------------ ------------------------------------------------------   ------------------------------------------------------
Volumes (in thousand metric tons)                                            20,192             18,386  
                                                                                       
Net Sales                                                                             $          9,740                      $         10,852  
                                                                                       
Gross Profit                                                                          $            454                      $            808  
                                                                                       
Selling, general and administrative expense                                           $           (155                    )                    $           (132                    )
                                                                                       
Foreign exchange (losses) gains - net                                    $            (62                    )                    $             39  
                                                                                       
EBIT attributable to noncontrolling interests                                         $              3                      $            (21                    )
                                                                                       
Other income (expense) - net                                                          $             53                      $             11  
                                                                                       
Income (loss) from affiliates                                                         $            (15                    )                    $ --  
                                                                                       
Segment EBIT                                                                          $            278                      $            705  
                                                                                209               (183                    )
   Mark-to-market timing differences
                                                                     --                (10                    )
   Certain (gains) & charges
                                                                   -------------------- -------------- -------------------- -------------------- -------------- --------------------
Adjusted Segment EBIT                                                                 $            487                      $            512  
                                                                                       
Certain (gains) & charges, Net income (loss) attributable to Bunge                    $ --                      $             (8                    )

Processing (2)

                                                  Three Months Ended
                                     ------------------------------------------------------------------------------
(US$ in millions)                                Mar 31, 2024                             Mar 31, 2023
------------------------------------ ----------------------------------  --------------------------------------------
Processing EBIT                                         $            180                    $  637  
                                                  231   (223                    )
   Mark-to-market timing differences
                                       --    (10                    )
   Certain (gains) & charges
                                     -------------------- -------------- -------------------- ---- --------------------

Higher results in Europe and Asia crush value chains were partially offset by lower results in North and South America.

Merchandising (2)

                                                       Three Months Ended
                                     ----------------------------------------------------------------------------------------
(US$ in millions)                                          Mar 31, 2024                                   Mar 31, 2023
------------------------------------ ------------------------------------------------------   ----------------------------------
Merchandising EBIT                                      $             98                      $             68
                                                  (22                    )               40
   Mark-to-market timing differences
                                       --     --
   Certain (gains) & charges
                                     -------------------- -------------- -------------------- -------------------- --------------

Lower results were primarily driven by our global grains and oils value chains where higher volumes were more than offset by lower margins.

Refined & Specialty Oils

                                                                                                Three Months Ended
                                                                   ------------------------------------------------------------------------------------------------------------
(US$ in millions, except per share data)                                                 Mar 31, 2024                                             Mar 31, 2023
------------------------------------------------------------------ ------------------------------------------------------   ------------------------------------------------------
Volumes (in thousand metric tons)                                             2,195              2,146  
                                                                                       
Net Sales                                                                             $          3,240                      $          3,888  
                                                                                       
Gross Profit                                                                          $            359                      $            342  
                                                                                       
Selling, general and administrative expense                                           $           (100                    )                    $            (95                    )
                                                                                       
Foreign exchange (losses) gains - net                                    $            (11                    )                    $              5  
                                                                                       
EBIT attributable to noncontrolling interests                                         $             (6                    )                    $             (4                    )
                                                                                       
Other income (expense) - net                                                          $            (16                    )                    $            (15                    )
                                                                                       
Segment EBIT                                                                          $            226                      $            233  
                                                                                (22                    )                1  
   Mark-to-market timing differences
                                                                     --     --  
   Certain (gains) & charges
                                                                   -------------------- -------------- -------------------- -------------------- -------------- --------------------
Adjusted Segment EBIT                                                                 $            204                      $            234  
                                                                                       
Certain (gains) & charges, Net income (loss) attributable to Bunge                    $ --                      $ --  

Refined & Specialty Oils Summary

Higher results in Europe were more than offset by lower results in North America and Asia. Results in South America were in line with last year.

Milling

                                                                                                Three Months Ended
                                                                   ------------------------------------------------------------------------------------------------------------
(US$ in millions, except per share data)                                                 Mar 31, 2024                                             Mar 31, 2023
------------------------------------------------------------------ ------------------------------------------------------   ------------------------------------------------------
Volumes (in thousand metric tons)                                               874                821  
                                                                                       
Net Sales                                                                             $            381                      $            515  
                                                                                       
Gross Profit                                                                          $             60                      $             31  
                                                                                       
Selling, general and administrative expense                                           $            (25                    )                    $            (21                    )
                                                                                       
Other income (expense) - net                                                          $             (2                    )                    $             (1                    )
                                                                                       
Segment EBIT                                                                          $             33                      $              9  
                                                                                 (5                    )                1  
   Mark-to-market timing differences
                                                                     --     --  
   Certain (gains) & charges
                                                                   -------------------- -------------- -------------------- -------------------- -------------- --------------------
Adjusted Segment EBIT                                                                 $             28                      $             10  
                                                                                       
Certain (gains) & charges, Net income (loss) attributable to Bunge                    $ --                      $ --  

Milling Summary

Higher results in the quarter were driven by South America reflecting improved margins in milling operations and a more favorable origination market environment.

Corporate and Other

                                                                                            Three Months Ended
                                                                   ----------------------------------------------------------------------------------------------------
(US$ in millions, except per share data)                                             Mar 31, 2024                                         Mar 31, 2023
------------------------------------------------------------------ ----------------------------------------------   ------------------------------------------------------
Gross Profit                                                                          $      2                      $ --  
                                                                               
Selling, general and administrative expense                                           $   (159                    )                    $           (105                    )
                                                                               
Foreign exchange (losses) gains - net                                    $     (5                    )                    $              5  
                                                                               
EBIT attributable to noncontrolling interests                                         $      1                      $ --  
                                                                               
Other income (expense) - net                                                          $     33                      $             20  
                                                                               
Segment EBIT                                                                          $   (128                    )                    $            (80                    )
                                                                         61     --  
   Certain (gains) & charges
                                                                   -------------------- ------ -------------------- -------------------- -------------- --------------------
Adjusted Segment EBIT                                                                 $    (67                    )                    $            (80                    )
                                                                               
Certain (gains) & charges, Net income (loss) attributable to Bunge                    $     61                      $ --  

Corporate

                                                     Three Months Ended
                             --------------------------------------------------------------------------------------------------
(US$ in millions)                             Mar 31, 2024                                        Mar 31, 2023
---------------------------- --------------------------------------------   ------------------------------------------------------
Corporate EBIT                                  $ (140                    )                    $            (87                    )
                                 61     --  
   Certain (gains) & charges
                             -------------------- ---- -------------------- -------------------- -------------- --------------------

Other

                                     Three Months Ended
                             --------------------------------------------------------------------
(US$ in millions)                        Mar 31, 2024                        Mar 31, 2023
---------------------------- ----------------------------------  ----------------------------------
Other EBIT                                      $             12                    $              7
                               --   --
   Certain (gains) & charges
                             -------------------- -------------- -------------------- --------------

Corporate and Other Summary

The decrease in Corporate expenses primarily reflected the timing of performance-based compensation. Higher Other results are related to Bunge Ventures and our captive insurance program.

Non-core Segments

Sugar & Bioenergy

                                                                           Three Months Ended
                                                                   --------------------------------------------------------------------
(US$ in millions, except per share data)                                       Mar 31, 2024                        Mar 31, 2023
------------------------------------------------------------------ ----------------------------------  ----------------------------------
Net Sales                                                                             $             43                    $             64
                                                                  
Gross Profit                                                                          $              1                    $ --
                                                                  
Income (loss) from affiliates                                                         $             23                    $             19
                                                                  
Segment EBIT                                                                          $             24                    $             19
                                                                     --   --
   Certain (gains) & charges
                                                                   -------------------- -------------- -------------------- --------------
Adjusted Segment EBIT                                                                 $             24                    $             19
                                                                  
Certain (gains) & charges, Net income (loss) attributable to Bunge                    $ --                    $ --

Sugar & Bioenergy Summary

Improved performance was primarily driven by higher sugar volumes and prices, more than offsetting lower ethanol prices.

Cash Flow

                                                                                   Three Months Ended
                                                                ----------------------------------------------------------------------------------------
                                                              Mar 31, 2024                                   Mar 31, 2023
                                                                --------------------------------------------   --------------------------------------------
Cash provided by (used for) operating activities                                   $  994                      $  931  
                                                                -------------------- ---- -------------------- -------------------- ---- --------------------
Certain reconciling items to Adjusted funds from operations (4)   (480                    )   (306                    )
                                                                -------------------- ---- -------------------- -------------------- ---- --------------------

Cash provided by operations in the three months ended March 31, 2024 was $994 million compared to $931 million in the same period last year. The slight increase in cash provided by operating activities was primarily driven by net changes in working capital, partially offset by lower reported net income. Adjusted funds from operations (FFO) was $514 million compared to $625 million in the prior year.(4)

Income Taxes

For the three months ended March 31, 2024, income tax expense was $117 million compared to $183 million in the prior year. The decrease was primarily due to lower pre-tax income.

Outlook(5)

Taking into account first quarter results and the current margin environment and forward curves, we continue to expect full-year 2024 adjusted EPS of approximately $9.00.

In Agribusiness, full-year results are forecasted to be similar to our previous outlook and down from last year primarily due to lower results in Processing where margins remain compressed in most regions.

In Refined and Specialty Oils, full-year results are expected to be similar to our previous outlook and down from the record prior year reflecting a shift in the supply environment, particularly in the U.S.

In Milling, full-year results are expected to be similar to our previous outlook and up from last year.

In Corporate and Other, full-year results are expected to be similar to our previous outlook and up from last year.

In Non-Core, full-year results in the sugar and bioenergy joint venture are expected to be similar to our previous outlook and significantly down from last year reflecting lower Brazilian ethanol prices.

Additionally, the Company expects the following for 2024: an adjusted annual effective tax rate of 22% to 25%; net interest expense in the range of $280 to $310 million, which is down from our previous expectation of $300 to $330 million; capital expenditures in the range of $1.2 to $1.4 billion; and depreciation and amortization of approximately $450 million.

Conference Call and Webcast Details

Bunge Global SA's management will host a conference call at 8:00 a.m. Eastern (7:00 a.m. Central) on Wednesday, April 24, 2024 to discuss the Company's results.

Additionally, a slide presentation to accompany the discussion of results will be posted on www.bunge.com.

To access the webcast, go to "Events & Presentations" under "News & Events" in the "Investor Center" section of the company's website. Select "Q1 2024 Bunge Global SA Conference Call" and follow the prompts. Please go to the website at least 15 minutes prior to the call to register and download any necessary audio software.

To listen to the call, please dial 1-844-735-3666. If you are located outside the United States or Canada, dial 1-412-317-5706. Please dial in five to 10 minutes before the scheduled start time. The call will also be webcast live at www.bunge.com.

A replay of the call will be available later in the day on April 24, 2024, continuing through May 24, 2024. To listen to it, please dial 1-877-344-7529 in the United States, 1-855-669-9658 in Canada, or 1-412-317-0088 in other locations. When prompted, enter confirmation code 6571723.

About Bunge

At Bunge (NYSE: BG), our purpose is to connect farmers to consumers to deliver essential food, feed and fuel to the world. With more than two centuries of experience, unmatched global scale and deeply rooted relationships, we work to strengthen global food security, increase sustainability where we operate, and help communities prosper. As the world's leader in oilseed processing and a leading producer and supplier of specialty plant-based oils and fats, we value our partnerships with farmers to bring quality products from where they're grown to where they're consumed. At the same time, we collaborate with our customers to develop tailored and innovative solutions to meet evolving dietary needs and trends in every part of the world. Our Company has its registered office in Geneva, Switzerland and its corporate headquarters in St. Louis, Missouri. We have approximately 23,000 dedicated employees working across approximately 300 facilities located in more than 40 countries.

Website Information

We routinely post important information for investors on our website, www.bunge.com, in the "Investors" section. We may use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, U.S. Securities and Exchange Commission ("SEC") filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

Cautionary Statement Concerning Forward Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward looking statements to encourage companies to provide prospective information to investors. This press release includes forward looking statements that reflect our current expectations and projections about our future results, performance, prospects and opportunities. Forward looking statements include all statements that are not historical in nature. We have tried to identify these forward looking statements by using words including "may," "will," "should," "could," "expect," "anticipate," "believe," "plan," "intend," "estimate," "continue" and similar expressions. These forward looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward looking statements. The following factors, among others, could cause actual results to differ from these forward looking statements:

the impact on our employees, operations, and facilities from the war in Ukraine and the resulting economic and other sanctions imposed on Russia, including the impact on us resulting from the continuation and/or escalation of the war and sanctions against Russia; the effect of weather conditions and the impact of crop and animal disease on our business; the impact of global and regional economic, agricultural, financial and commodities market, political, social and health conditions; changes in government policies and laws affecting our business, including agricultural and trade policies, financial markets regulation and environmental, tax and biofuels regulation; the impact of seasonality; the impact of government policies and regulations; the outcome of pending regulatory and legal proceedings; our ability to complete, integrate and benefit from acquisitions, divestitures, joint ventures and strategic alliances, including without limitation Bunge's pending business combination with Viterra Limited ("Viterra"); the impact of industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products that we sell and use in our business, fluctuations in energy and freight costs and competitive developments in our industries; the effectiveness of our capital allocation plans, funding needs and financing sources; the effectiveness of our risk management strategies; operational risks, including industrial accidents, natural disasters, pandemics or epidemics and cybersecurity incidents; changes in foreign exchange policy or rates; the impact of our dependence on third parties; our ability to attract and retain executive management and key personnel; and other factors affecting our business generally.

The forward looking statements included in this release are made only as of the date of this release, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward looking statements to reflect subsequent events or circumstances.

You should refer to "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 22, 2024.

Additional Financial Information

Certain gains and (charges), quarter-to-date

The following table provides a summary of certain gains and (charges) that may be of interest to investors, including a description of these items and their effect on Net income (loss) attributable to Bunge, Earnings per share diluted and Segment EBIT for the three month periods ended March 31, 2024 and 2023.

(US$ in millions, except per share data)                                       Net Income (Loss)                                                                                  Earnings                                                                                        Segment                                            
                                                                                Attributable to                                                                                                      Per Share                                                                                                           EBIT
                                                                                     Bunge                                                                                                          Diluted (6)
---------------------------------------- ----------------------------------------------------------------------------------------     -------------------- ----------------------------------------------------------------------------------------     -------------------- ----------------------------------------------------------------------------------------     --------------------
Three Months Ended March 31,                    2024                        2023                         2024                        2023                         2024                        2023                 
---------------------------------------- -------------------- -------------- -------------------- ----------------------------------  -------------------- -------------------- -------------- -------------------- ----------------------------------  -------------------- -------------------- -------------- -------------------- ----------------------------------  --------------------
                                                                                                                                                                                                
Core Segments:                                              $ --                      $              8                      $ --                      $           0.05                      $ --                      $             10  
                                         -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- --------------------
                                                            $ --                      $              8                      $ --                      $           0.05                      $ --                      $             10  
   Agribusiness
                                         -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- --------------------
                                           --                  8     --               0.05     --                 10  
      Ukraine-Russia War
                                                                                                                                                                                                                   
    
                                                                                                                                                                                                                   
    
                                                            $ --                      $ --                      $ --                      $ --                      $ --                      $ --  
   Refined and Specialty Oils
                                         -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- --------------                      -------------------- -------------- -------------------- -------------------- -------------- --------------------
                                                                                                                                                                                                                   
    
                                                            $ --                      $ --                      $ --                      $ --                      $ --                      $ --  
   Milling
                                         -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- --------------------
                                                                                                                                                                                                                   
    
                                                                                                                                                                                                                   
    
Corporate and Other:                                        $            (61                    )                    $ --                      $          (0.42                    )                    $ --                      $            (61                    )                    $ --  
                                         -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- --------------------
                                                      (61                    )   --              (0.42                    )   --                (61                    )   --  
      Acquisition and integration costs
                                                                                                                                                                                                                   
    
Non-core Segment:                                           $ --                      $ --                      $ --                      $ --                      $ --                      $ --  
                                         -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------- -------------------- -------------------- --------------                      -------------------- -------------- -------------------- -------------------- -------------- --------------------
                                                            $ --                      $ --                      $ --                      $ --                      $ --                      $ --  
   Sugar & Bioenergy
                                                                                                                                                                                                
                                                                                                                                                                                                
                                         ------------------------------------------------------   ----------------------------------  -------------------- ------------------------------------------------------   ----------------------------------  -------------------- ------------------------------------------------------   ----------------------------------  --------------------
Total                                                       $            (61                    )                    $              8                      $          (0.42                    )                    $           0.05                      $            (61                    )                    $             10  
                                         ==================== ============== ==================== ==================== ============== ==================== ==================== ============== ==================== ==================== ============== ==================== ==================== ============== ==================== ==================== ============== ====================
                                                                                                                                                                                                

Core Segments

Agribusiness

EBIT for the three months ended March 31, 2023 included a mark-to-market gain of $10 million, in Cost of goods sold, related to inventory recovered from our Mykolaiv and other facilities in Ukraine. The circumstances allowing for recovery of these inventories did not exist and were unforeseeable when the inventory reserves were initially recorded in 2022 in conjunction with the Ukraine-Russia war.

Corporate and Other

Net income for the three months ended March 31, 2024 included $61 million of acquisition and integration costs (net of $4 million in tax benefits) related to the announced business combination agreement with Viterra. Specifically, the Company recorded $4 million of pre-tax charges within Interest expense for financing related fees, and $61 million of pre-tax charges within SG&A for other acquisition and integration related costs.

Consolidated Earnings Data (Unaudited)

                                                                                         Three Months Ended
                                                                                                                 March 31,
                                                                   ----------------------------------------------------------------------------------------------
(US$ in millions, except per share data)                               2024        2023   
------------------------------------------------------------------ -------------------- ------- -------------------- -------------------- ------- --------------------
Net sales                                                                             $  13,417                      $  15,328  
Cost of goods sold                                                   (12,541                    )   (14,147                    )
                                                                   -------------------- ------- -------------------- -------------------- ------- --------------------
Gross profit                                                             876       1,181  
Selling, general and administrative expenses                            (439                    )      (353                    )
Foreign exchange (losses) gains - net                       (78                    )        49  
Other income (expense) - net                                 68          15  
Income (loss) from affiliates                                              8          19  
EBIT attributable to noncontrolling interest (a) (1)                      (2                    )       (25                    )
                                                                   -------------------- ------- -------------------- -------------------- ------- --------------------
Total Segment EBIT                                                       433         886  
Interest income                                                           42          43  
Interest expense                                                        (108                    )      (112                    )
Income tax (expense) benefit                                            (117                    )      (183                    )
Noncontrolling interest share of interest and tax (a) (1)                 (6                    )        (2                    )
                                                                   -------------------- ------- -------------------- -------------------- ------- --------------------
Net income (loss) attributable to Bunge (1)                                           $     244                      $     632  
                                                                   ==================== ======= ==================== ==================== ======= ====================
                                                                                
Net income (loss) attributable to Bunge shareholders - diluted (6)                    $    1.68                      $    4.15  
                                                                   ==================== ======= ==================== ==================== ======= ====================
(a) The line items "EBIT attributable to noncontrolling interest" and "Noncontrolling interest share of interest and tax" when combined, represent consolidated Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests on a U.S. GAAP basis of presentation.

Condensed Consolidated Balance Sheets (Unaudited)

                                   March 31,                       December 31,
(US$ in millions)                                       2024                              2023
----------------------------------------- ------------------------------                       ------------------------------
Assets                                                    
Cash and cash equivalents                                    $      2,939                      $      2,602
Trade accounts receivable, net                   2,285          2,592
Inventories (a)                                  7,505          7,105
Other current assets                             4,011          4,051
                                          -------------------- ----------                      -------------------- ----------
Total current assets                            16,740         16,350
Property, plant and equipment, net               4,620          4,541
Operating lease assets                             922            926
Goodwill and other intangible assets, net          860            887
Investments in affiliates                        1,296          1,280
Other non-current assets                         1,383          1,388
                                          -------------------- ----------                      -------------------- ----------
Total assets                                                 $     25,821                      $     25,372
                                          ==================== ==========                      ==================== ==========
                                       
Liabilities and Equity                                    
Short-term debt                                              $      1,010                      $        797
Current portion of long-term debt                    6              5
Trade accounts payable                           4,503          3,664
Current operating lease obligations                315            308
Other current liabilities                        2,595          2,913
                                          -------------------- ----------                      -------------------- ----------
Total current liabilities                        8,429          7,687
Long-term debt                                   4,079          4,080
Non-current operating lease obligations            557            566
Other non-current liabilities                    1,227          1,224
                                          -------------------- ----------                      -------------------- ----------
Total liabilities                               14,292         13,557
Redeemable noncontrolling interest                   1              1
Total equity                                    11,528         11,814
                                          -------------------- ----------                      -------------------- ----------
(a) Includes readily marketable inventories of $6,218 million and $5,837 million at March 31, 2024 and December 31, 2023, respectively. Of the total RMI, $4,785 million and $4,242 million can be attributable to merchandising activities at March 31, 2024 and December 31, 2023, respectively.

Condensed Consolidated Statements of Cash Flows (Unaudited)

                                                                                                                                       Three Months Ended
                                                                                                                                                               March 31,
                                                                                                --------------------------------------------------------------------------------------------------------------------------------
(US$ in millions)                                                                                      2024                 2023       
----------------------------------------------------------------------------------------------- -------------------- -------------- --------------------                      -------------------- -------------- --------------------
Operating Activities                                                                                                                     
Net income (loss) (1)                                                                                              $            252                        $            659  
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:                                          
                                                                                                              (2                    )                (50                    )
   Foreign exchange (gain) loss on net debt
                                                                                                             112                  102  
   Depreciation, depletion and amortization
                                                                                                              17                   17  
   Share-based compensation expense
                                                                                                             (10                    )                 11  
   Deferred income tax expense (benefit)
                                                                                                              (8                    )                (19                    )
   Results from affiliates
                                                                                                              23                   10  
   Other, net
                                                                                                                                         
   Changes in operating assets and liabilities, excluding the effects of acquisitions:
                                                                                                             284                    5  
   Trade accounts receivable
                                                                                                            (484                    )               (434                    )
   Inventories
                                                                                                              34                   15  
   Secured advances to suppliers
                                                                                                             774                  802  
   Trade accounts payable and accrued liabilities
                                                                                                             (30                    )               (119                    )
   Advances on sales
                                                                                                             249                 (424                    )
   Net unrealized (gain) loss on derivative contracts
                                                                                                            (227                    )                141  
   Margin deposits
                                                                                                             (11                    )                128  
   Recoverable and income taxes, net
                                                                                                              (6                    )                 13  
   Marketable securities
                                                                                                              27                   74  
   Other, net
                                                                                                -------------------- -------------- --------------------                      -------------------- -------------- --------------------
                                                                                                             994                  931  
      Cash provided by (used for) operating activities
Investing Activities                                                                                                                     
Payments made for capital expenditures                                                                      (236                    )               (173                    )
Proceeds from investments                                                                                    239                    1  
Payments for investments                                                                                    (351                    )                 (4                    )
Settlement of net investment hedges                                                                           (9                    )     --  
Proceeds from beneficial interest in securitized trade receivables                                --                   61  
Proceeds from sales of businesses and property, plant and equipment                               --                  159  
Payments for investments in affiliates                                                                       (16                    )                (94                    )
Other, net                                                                                                   (23                    )                 95  
                                                                                                -------------------- -------------- --------------------                      -------------------- -------------- --------------------
                                                                                                            (396                    )                 45  
      Cash provided by (used for) investing activities
Financing Activities                                                                                                                     
Net borrowings (repayments) of short-term debt                                                               224                    3  
Net proceeds (repayments) of long-term debt                                                                   14                  999  
Repurchases of registered or common shares                                                                  (400                    )     --  
Dividends paid to registered or common shareholders                                                          (95                    )                (94                    )
Contributions from (Return of capital to) noncontrolling interest                                             15                    2  
Other, net                                                                                                   (17                    )                 (9                    )
                                                                                                -------------------- -------------- --------------------                      -------------------- -------------- --------------------
                                                                                                            (259                    )                901  
      Cash provided by (used for) financing activities
Effect of exchange rate changes on cash and cash equivalents, and restricted cash                             (9                    )                 28  
                                                                                                -------------------- -------------- --------------------                      -------------------- -------------- --------------------
Net increase (decrease) in cash and cash equivalents and restricted cash                                     330                1,905  
Cash and cash equivalents, and restricted cash - beginning of period                                       2,623                1,152  
                                                                                                -------------------- -------------- --------------------                      -------------------- -------------- --------------------

Definition and Reconciliation of Non-GAAP Measures

This earnings release contains certain "non-GAAP financial measures" as defined in Regulation G of the Securities Exchange Act of 1934. Bunge has reconciled these non-GAAP financial measures to the most directly comparable U.S. GAAP measures below. These measures may not be comparable to similarly titled measures used by other companies.

Total Segment EBIT and Adjusted Total Segment EBIT

Bunge uses segment earnings before interest and tax ("Segment EBIT") to evaluate the operating performance of its individual segments. Segment EBIT excludes EBIT attributable to noncontrolling interests. Bunge also uses Core Segment EBIT, Non-core Segment EBIT, Corporate and Other EBIT and Total Segment EBIT to evaluate the operating performance of Bunge's Core reportable segments, Non-core reportable segments and Total reportable segments together with Corporate and Other. Core Segment EBIT is the aggregate of the earnings before interest and taxes of each of Bunge's Agribusiness, Refined and Specialty Oils, and Milling segments. Non-core Segment EBIT is the earnings before interest and taxes of Bunge's Sugar & Bioenergy segment. Total Segment EBIT is the aggregate of the earnings before interest and taxes of Bunge's Core and Non-core reportable segments, together with its Corporate and Other activities.

Adjusted Core Segment EBIT, Adjusted Non-Core Segment EBIT, Adjusted Corporate and Other EBIT and Adjusted Total Segment EBIT, are calculated by excluding temporary mark-to-market timing differe

Do not sell my personal information

Copyright © 2024. All market data is provided by Barchart Solutions. Information is provided "as is" and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.